Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Exploring how nucleolar antigens in cancer cells reveal new pathways for diagnostics and immunotherapy, focusing on NPM1, NOL9, and B23 proteins.